A Long Non-coding RNA, LOC157273, Is an Effector Transcript at the Chromosome 8p23.1-PPP1R3B Metabolic Traits and Type 2 Diabetes Risk Locus

AimsCausal transcripts at genomic loci associated with type 2 diabetes (T2D) are mostly unknown. The chr8p23.1 variant rs4841132, associated with an insulin-resistant diabetes risk phenotype, lies in the second exon of a long non-coding RNA (lncRNA) gene, LOC157273, located 175 kilobases from PPP1R3...

Full description

Bibliographic Details
Main Authors: Alisa K. Manning, Anton Scott Goustin, Erica L. Kleinbrink, Pattaraporn Thepsuwan, Juan Cai, Donghong Ju, Aaron Leong, Miriam S. Udler, James Bentley Brown, Mark O. Goodarzi, Jerome I. Rotter, Robert Sladek, James B. Meigs, Leonard Lipovich
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-07-01
Series:Frontiers in Genetics
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fgene.2020.00615/full
id doaj-9d4e263c3f284be6a793db9ae92b53aa
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Alisa K. Manning
Alisa K. Manning
Alisa K. Manning
Anton Scott Goustin
Erica L. Kleinbrink
Pattaraporn Thepsuwan
Juan Cai
Donghong Ju
Donghong Ju
Aaron Leong
Aaron Leong
Aaron Leong
Miriam S. Udler
Miriam S. Udler
James Bentley Brown
James Bentley Brown
James Bentley Brown
Mark O. Goodarzi
Jerome I. Rotter
Robert Sladek
Robert Sladek
Robert Sladek
James B. Meigs
James B. Meigs
James B. Meigs
Leonard Lipovich
Leonard Lipovich
spellingShingle Alisa K. Manning
Alisa K. Manning
Alisa K. Manning
Anton Scott Goustin
Erica L. Kleinbrink
Pattaraporn Thepsuwan
Juan Cai
Donghong Ju
Donghong Ju
Aaron Leong
Aaron Leong
Aaron Leong
Miriam S. Udler
Miriam S. Udler
James Bentley Brown
James Bentley Brown
James Bentley Brown
Mark O. Goodarzi
Jerome I. Rotter
Robert Sladek
Robert Sladek
Robert Sladek
James B. Meigs
James B. Meigs
James B. Meigs
Leonard Lipovich
Leonard Lipovich
A Long Non-coding RNA, LOC157273, Is an Effector Transcript at the Chromosome 8p23.1-PPP1R3B Metabolic Traits and Type 2 Diabetes Risk Locus
Frontiers in Genetics
insulin resistance
hepatic glycogen storage
long non-coding RNA
metabolism
type 2 diabetes
regulatory mechanisms
author_facet Alisa K. Manning
Alisa K. Manning
Alisa K. Manning
Anton Scott Goustin
Erica L. Kleinbrink
Pattaraporn Thepsuwan
Juan Cai
Donghong Ju
Donghong Ju
Aaron Leong
Aaron Leong
Aaron Leong
Miriam S. Udler
Miriam S. Udler
James Bentley Brown
James Bentley Brown
James Bentley Brown
Mark O. Goodarzi
Jerome I. Rotter
Robert Sladek
Robert Sladek
Robert Sladek
James B. Meigs
James B. Meigs
James B. Meigs
Leonard Lipovich
Leonard Lipovich
author_sort Alisa K. Manning
title A Long Non-coding RNA, LOC157273, Is an Effector Transcript at the Chromosome 8p23.1-PPP1R3B Metabolic Traits and Type 2 Diabetes Risk Locus
title_short A Long Non-coding RNA, LOC157273, Is an Effector Transcript at the Chromosome 8p23.1-PPP1R3B Metabolic Traits and Type 2 Diabetes Risk Locus
title_full A Long Non-coding RNA, LOC157273, Is an Effector Transcript at the Chromosome 8p23.1-PPP1R3B Metabolic Traits and Type 2 Diabetes Risk Locus
title_fullStr A Long Non-coding RNA, LOC157273, Is an Effector Transcript at the Chromosome 8p23.1-PPP1R3B Metabolic Traits and Type 2 Diabetes Risk Locus
title_full_unstemmed A Long Non-coding RNA, LOC157273, Is an Effector Transcript at the Chromosome 8p23.1-PPP1R3B Metabolic Traits and Type 2 Diabetes Risk Locus
title_sort long non-coding rna, loc157273, is an effector transcript at the chromosome 8p23.1-ppp1r3b metabolic traits and type 2 diabetes risk locus
publisher Frontiers Media S.A.
series Frontiers in Genetics
issn 1664-8021
publishDate 2020-07-01
description AimsCausal transcripts at genomic loci associated with type 2 diabetes (T2D) are mostly unknown. The chr8p23.1 variant rs4841132, associated with an insulin-resistant diabetes risk phenotype, lies in the second exon of a long non-coding RNA (lncRNA) gene, LOC157273, located 175 kilobases from PPP1R3B, which encodes a key protein regulating insulin-mediated hepatic glycogen storage in humans. We hypothesized that LOC157273 regulates expression of PPP1R3B in human hepatocytes.MethodsWe tested our hypothesis using Stellaris fluorescent in situ hybridization to assess subcellular localization of LOC157273; small interfering RNA (siRNA) knockdown of LOC157273, followed by RT-PCR to quantify LOC157273 and PPP1R3B expression; RNA-seq to quantify the whole-transcriptome gene expression response to LOC157273 knockdown; and an insulin-stimulated assay to measure hepatocyte glycogen deposition before and after knockdown.ResultsWe found that siRNA knockdown decreased LOC157273 transcript levels by approximately 80%, increased PPP1R3B mRNA levels by 1.7-fold, and increased glycogen deposition by >50% in primary human hepatocytes. An A/G heterozygous carrier (vs. three G/G carriers) had reduced LOC157273 abundance due to reduced transcription of the A allele and increased PPP1R3B expression and glycogen deposition.ConclusionWe show that the lncRNA LOC157273 is a negative regulator of PPP1R3B expression and glycogen deposition in human hepatocytes and a causal transcript at an insulin-resistant T2D risk locus.
topic insulin resistance
hepatic glycogen storage
long non-coding RNA
metabolism
type 2 diabetes
regulatory mechanisms
url https://www.frontiersin.org/article/10.3389/fgene.2020.00615/full
work_keys_str_mv AT alisakmanning alongnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus
AT alisakmanning alongnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus
AT alisakmanning alongnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus
AT antonscottgoustin alongnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus
AT ericalkleinbrink alongnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus
AT pattarapornthepsuwan alongnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus
AT juancai alongnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus
AT donghongju alongnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus
AT donghongju alongnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus
AT aaronleong alongnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus
AT aaronleong alongnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus
AT aaronleong alongnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus
AT miriamsudler alongnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus
AT miriamsudler alongnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus
AT jamesbentleybrown alongnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus
AT jamesbentleybrown alongnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus
AT jamesbentleybrown alongnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus
AT markogoodarzi alongnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus
AT jeromeirotter alongnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus
AT robertsladek alongnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus
AT robertsladek alongnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus
AT robertsladek alongnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus
AT jamesbmeigs alongnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus
AT jamesbmeigs alongnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus
AT jamesbmeigs alongnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus
AT leonardlipovich alongnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus
AT leonardlipovich alongnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus
AT alisakmanning longnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus
AT alisakmanning longnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus
AT alisakmanning longnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus
AT antonscottgoustin longnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus
AT ericalkleinbrink longnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus
AT pattarapornthepsuwan longnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus
AT juancai longnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus
AT donghongju longnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus
AT donghongju longnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus
AT aaronleong longnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus
AT aaronleong longnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus
AT aaronleong longnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus
AT miriamsudler longnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus
AT miriamsudler longnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus
AT jamesbentleybrown longnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus
AT jamesbentleybrown longnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus
AT jamesbentleybrown longnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus
AT markogoodarzi longnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus
AT jeromeirotter longnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus
AT robertsladek longnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus
AT robertsladek longnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus
AT robertsladek longnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus
AT jamesbmeigs longnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus
AT jamesbmeigs longnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus
AT jamesbmeigs longnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus
AT leonardlipovich longnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus
AT leonardlipovich longnoncodingrnaloc157273isaneffectortranscriptatthechromosome8p231ppp1r3bmetabolictraitsandtype2diabetesrisklocus
_version_ 1724514370836234240
spelling doaj-9d4e263c3f284be6a793db9ae92b53aa2020-11-25T03:44:31ZengFrontiers Media S.A.Frontiers in Genetics1664-80212020-07-011110.3389/fgene.2020.00615521982A Long Non-coding RNA, LOC157273, Is an Effector Transcript at the Chromosome 8p23.1-PPP1R3B Metabolic Traits and Type 2 Diabetes Risk LocusAlisa K. Manning0Alisa K. Manning1Alisa K. Manning2Anton Scott Goustin3Erica L. Kleinbrink4Pattaraporn Thepsuwan5Juan Cai6Donghong Ju7Donghong Ju8Aaron Leong9Aaron Leong10Aaron Leong11Miriam S. Udler12Miriam S. Udler13James Bentley Brown14James Bentley Brown15James Bentley Brown16Mark O. Goodarzi17Jerome I. Rotter18Robert Sladek19Robert Sladek20Robert Sladek21James B. Meigs22James B. Meigs23James B. Meigs24Leonard Lipovich25Leonard Lipovich26Clinical and Translational Epidemiology Unit, Mongan Institute, Massachusetts General Hospital, Boston, MA, United StatesDepartment of Medicine, Harvard Medical School, Boston, MA, United StatesPrograms in Metabolism and Medical & Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, United StatesCenter for Molecular Medicine & Genetics, Wayne State University, Detroit, MI, United StatesCenter for Molecular Medicine & Genetics, Wayne State University, Detroit, MI, United StatesCenter for Molecular Medicine & Genetics, Wayne State University, Detroit, MI, United StatesCenter for Molecular Medicine & Genetics, Wayne State University, Detroit, MI, United StatesCenter for Molecular Medicine & Genetics, Wayne State University, Detroit, MI, United StatesKarmanos Cancer Institute at Wayne State University, Detroit, MI, United StatesPrograms in Metabolism and Medical & Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, United StatesCenter for Genomic Medicine, Massachusetts General Hospital, Boston, MA, United StatesDivision of General Internal Medicine, Massachusetts General Hospital, Boston, MA, United StatesCenter for Genomic Medicine, Massachusetts General Hospital, Boston, MA, United StatesDiabetes Unit, Massachusetts General Hospital, Boston, MA, United StatesDepartment of Statistics, University of California, Berkeley, Berkeley, CA, United States0Centre for Computational Biology, University of Birmingham, Birmingham, United Kingdom1Computational Biosciences Group, Biosciences Area, Lawrence Berkeley National Laboratory, Berkeley, CA, United States2Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, United States3The Institute for Translational Genomics and Population Sciences, Department of Pediatrics, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA, United States4Department of Human Genetics, McGill University, Montréal, QC, Canada5Department of Medicine, McGill University, Montréal, QC, Canada6McGill University and Genome Québec Innovation Centre, Montréal, QC, CanadaDepartment of Medicine, Harvard Medical School, Boston, MA, United StatesPrograms in Metabolism and Medical & Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, United StatesDivision of General Internal Medicine, Massachusetts General Hospital, Boston, MA, United StatesCenter for Molecular Medicine & Genetics, Wayne State University, Detroit, MI, United States7Department of Neurology, School of Medicine, Wayne State University, Detroit, MI, United StatesAimsCausal transcripts at genomic loci associated with type 2 diabetes (T2D) are mostly unknown. The chr8p23.1 variant rs4841132, associated with an insulin-resistant diabetes risk phenotype, lies in the second exon of a long non-coding RNA (lncRNA) gene, LOC157273, located 175 kilobases from PPP1R3B, which encodes a key protein regulating insulin-mediated hepatic glycogen storage in humans. We hypothesized that LOC157273 regulates expression of PPP1R3B in human hepatocytes.MethodsWe tested our hypothesis using Stellaris fluorescent in situ hybridization to assess subcellular localization of LOC157273; small interfering RNA (siRNA) knockdown of LOC157273, followed by RT-PCR to quantify LOC157273 and PPP1R3B expression; RNA-seq to quantify the whole-transcriptome gene expression response to LOC157273 knockdown; and an insulin-stimulated assay to measure hepatocyte glycogen deposition before and after knockdown.ResultsWe found that siRNA knockdown decreased LOC157273 transcript levels by approximately 80%, increased PPP1R3B mRNA levels by 1.7-fold, and increased glycogen deposition by >50% in primary human hepatocytes. An A/G heterozygous carrier (vs. three G/G carriers) had reduced LOC157273 abundance due to reduced transcription of the A allele and increased PPP1R3B expression and glycogen deposition.ConclusionWe show that the lncRNA LOC157273 is a negative regulator of PPP1R3B expression and glycogen deposition in human hepatocytes and a causal transcript at an insulin-resistant T2D risk locus.https://www.frontiersin.org/article/10.3389/fgene.2020.00615/fullinsulin resistancehepatic glycogen storagelong non-coding RNAmetabolismtype 2 diabetesregulatory mechanisms